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abstract
Background: Bone graft material have been used extensively in bone healing and periodontal treatment. Alloplast such as 
hydroxyapatite are frequently used to repair and reconstruct bone defects. By merely applying hydroxyapatite for the treatment 
of bone is not fully effective yet to produce new bone regeneration. Locally applied high molecular hyaluronic acid (HA) has been 
shown to stimulate differentiation and migration of mesenchymal cells. Recent studies on regenerative surgical procedures indicate 
that reduction of bacterial burden at the wound site may improve the clinical outcome of regenerative therapy. Metronidazole has the 
greatest bacteriostatic effect. A clinical application of HA metronidazole gels during the surgical therapy may reduce the bacterial 
contamination of surgical wound site. Purpose: The purpose of this study was to examine the effect of combination hydroxyapatite 
and HA metronidazole gel 1% on osteoblast cell number after wound healing process in the wistar rats incisor tooth extraction socket. 
Method: Twenty seven wistar rats were divided randomly into 3 groups. The first group consisted of wistar rats given hydroxyapatite were 
subjected to the mandibular incisor extraction socket. The second group were given hydroxyapatite combined with HA metronidazole gel 
1%. The control group were filled with blood. Wistar rats were euthanized on day 14 and then preparation for histological examination 
was stained using hematoxylin-eosin and then the numbers of the osteoblasts were calculated. Result: The differences in each group 
were tested by one way Anova test (α=0.05). The numbers of osteoblasts in each group had a significant difference (p<0.05): the 
highest numbers of osteoblasts were found in the group that was given hydroxyapatite combined with HA metronidazole, followed by 
the lower numbers of osteoblasts in the hydroxyapatite group and the lowest numbers of osteoblasts were found in the control group. 
Conclusion: Adjunctive application of HA metronidazole to hydroxyapatite after tooth extraction increase the number of osteoblast 
in the treatment of bone defects on a wistar rat model. 
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introduction
Bone augmentation techniques are commonly 
employed in dentistry. The role of bone graft materials 
in regenerative procedures is based on that osteogenic, 
osteoinductive or osteoconductive potential. Alloplast 
include hydroxyapatite, collagen-based matrices, calcium 
sulfate, and tri-calcium phosphate is a synthetic body 
material that has ostoeconductive capacity. However, 
hydroxyapatite is not fully effective yet to produce new 
bone regeneration. Treatment of bone defects by using 
hydroxyapatite alone cannot be maximized in new bone 
forming. Indeed, hydroxyapatite were found enhance 
osteoblast differentiation, but combined hydroxyapatite 
collagen or growth factor together were shown to accelerate 
osteogenesis.1,2 One of many approaches of tissue 
engineering is to create a device of similar mechanical and 
biological properties to the one of the substituted tissue. 
The use of regenerative materials and antibacteria which 
is used in conjunction with hydroxyapatite can increase 
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the accomplishment of bone augmentation. It is expected 
that the use of regenerative materials such as hyaluronic 
acid, and antibacteria such as metronidazole which is 
used in conjunction with hydroxyapatite can increase the 
accomplishment of the bone healing. 
Bone healing is a complex process that involves local 
and systemic organic activity and osteoblast are some of the 
cells directly involved in this mechanism. There are three 
phases in bone healing including reactive phase (phase 
inflammation and granulation tissue formation), reparative 
phase (cartilage callus formation and deposition of lamellar 
bone) and remodeling phase (formation of bone contour). 
Osteoblasts plays an important role in the mineralization 
process. Osteoblast proliferating from the pre-existing bone 
beneath the calcified cartilage, and in conjunction with 
angiogenic activity, form bone on the calcified cartilage 
stratum. This bone formation process is endochondral 
ossification. Small bone defects, such as socket after tooth 
extraction, heal by direct synthesis of new bone to fill the 
defect. After extraction no bone formation occurred for 
the first week. At 8 days, new bone formation was noted 
throughout the alveolar bone, particularly under the wall but 
not on the surface of the bone lining the extraction socket. 
At 10 days, bone formation was noted on the surface of the 
socket wall. At 12 days, new bone formation continued along 
the socket wall and in the trabecular spaces surrounding the 
extraction site. Osteoblasts regulates calcium and phosphate 
concentrations. In addition osteoblasts also express alkaline 
phosphatase in high quantities to the plasma membrane. 
Osteoblasts as secretory metabolically active, producing a 
number of BMP-2, BMP-7 and growth factor. Osteoblasts 
also express RANKL and OPG expression products of 
osteoblasts occurs during bone remodeling.3,4
In the early stages of inflammation, the tissues will 
contain a large amount of Hyaluronic acid which is much 
needed for the process of bone regeneration. Hyaluronic 
acid (HA) is hyaluronan/hyaluronate which is a non-sulfated 
polysaccharide component from the glycosaminoglycan 
group with high molecular weight (10,000–10,000,000 
Da). HA serves to accelerate the process of regeneration 
by way of chemotaxis, proliferation and differentiation of 
mesenchymal cells and share the role as bone induction 
with osteogenic substance such as bone morphogenetic 
protein-2 (BMP-2) and osteopontin.4,5 HA is one of the 
essential components of extracellular matrix, which plays 
a predominant role in tissue morphogenesis, cell migration, 
differentiation, and adhesion which will contribute bone 
healing properties. In the medical world apart from being 
used for therapeutic in dentistry, hyaluronic acid is also used 
for the treatment of the skin, joints, hair and eyes. 6 
Recent studies on regenerative surgical procedures 
indicate that reduction of bacterial burden at the wound 
site may improve the clinical outcome of regenerative 
therapy. Metronidazole has the greatest bacteriostatic effect, 
particularly on Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, Prevotella oris and Staphylococcus 
aureus strains, which are commonly found in oral lesions. 
A clinical application of HA metronidazole gels during the 
surgical therapy may reduce the bacterial contamination 
of surgical wound site, thereby, lessening the risk of 
postsurgical infection and promoting more predictable 
regeneration.7 Considering that, no previous study exists on 
the use of hydroxyapatite combined with HA metronidazole 
as adjunctive to grafting process. The purpose of this study 
was to examine the effect of combination hydroxyapatite 
and HA metronidazole gel on osteoblast cell number after 
wound healing process in alveolar bone wistar rat.
materials and methods
The study is a laboratory experimental research with 
randomized post test only control group design. The 
sample used 27 wistar rats aged 8-16 weeks were divided 
randomly into 3 groups which had 9 wistar rat each. The 
study protocol had been approved by ethical Committee 
of Faculty of Dental Medicine Universitas Airlangga, 
Indonesia (No. 197/KKePK.FKG/XI/2015). The first 
group consisted of wistar rats given hydroxyapatite were 
subjected to the mandibular incisor extraction socket. 
The second group consisted of wistar rats that were given 
hydroxyapatite combined with HA metronidazole on the 
mandibular incisor extraction socket. The third group as 
control which the mandibular incisor extraction socket 
was filled with blood. The materials used in the present 
study were HA metronidazole with a concentration 1% in 
a gel form and hydroxyapatite. HA metronidazole gel 0.5 
mg was mixed with hydroxyapatite 0.5 mg in the same 
ratio 1: 1 were applied into the socket of dental extraction. 
The extraction cavity was then covered with coronally 
repositioned flap, sutured and compressed with the moist 
gauze. Animals were placed on a soft diet for two days 
post surgically. 
Prior to the treatment, the wistar male rats were 
acclimatized for one week. The rats were maintained in a 
40 cm x 30 cm x 15 cm size plastic cage. They were given 
the same food and drink during the adjustment period. 
The plastic cage was covered with woven wire, and the 
cage floor was covered with husk. The cage was placed 
in an isolated room with good ventilation and natural 
lighting. The rats was decaputated 14 days after application 
by injection of ketamine 50 mg/kg. Immediately after 
sacrifice, animals’ jaws were carefully dissected, and the 
experimental teeth with their surrounding bone tissue were 
block-sectioned using electric surgical saw. Blocks were 
immediately fixed in a 70% buffered formalin solution to 
prevent tissue changes so they do not decay, or harden, 
increase the refractive index of various tissue components 
and increase tissue affinity against paint materials. After 
complete decalcification, blocks were routinely processed 
and embedded in paraffin. Six mµ sections were cut 
in a buccolingual direction, mounted on glass slides, 
deparaffinized, hydrated and stained. After the 48 hours, 
the fixative was replaced with a new one and the tissues 
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were cut much smaller so that the fixation could penetrate 
evenly into the tissues. In the second stage, the fixation 
was left in the solution for 48 hours. After fixation the 
tissues were rinsed with running water for 6-9 hours, 
and then put in a HNO3 5% decalcification solution for 
1 hour. On the next stage, hematoxylin and eosin (H & 
e) stain was performed on the preparations for histology. 
Histomorphometric analysis was carried out on the healing 
sites. In each He stained slide, three digital images were 
captured at (×400) magnification. each group was observed 
with an OLYMPUS BX41 series microscope which is 
equipped with a D70 digital camera using the OLYSIA 
software. The intensity of the color in the osteoblast areas 
could be seen as a quantitative value. This research data was 
analysed by one way Anova statistical test and continued 
with Tukey HSD. 
results
Osteoblast obseved were found in the apical third of the 
tooth socket. Histological examination of all treated cavities 
sites demonstrated newly osteoblast of implemented 
materials. Figure 1 shows histological imaged that observed 
under the microscope.
Normality and homogenity tests were carried out 
first to obtain data of the research. The Kolmogorov-
Smirnov test was applied for normality test while the 
Levene test was used for homogeneity test. Results of the 
Kolmogorov-Smirnov test denoted the probability of each 
treatment group which were bigger than 0.05 (p>0.05). 
The values mean that all the data were taken from the 
symmetrical or normal distributions. In the Levene test 
result on osteoblasts sig = 0.977 means p>0.05 data was 
homogeneous. The data acquired was known normally 
and distributed homogeneously, next step one way Anova 
test was to carry out to determine the differences in the 
number of osteoblasts in all the three treatment groups. 
One way Anova test continued Tukey HSD test showed 
that the probability figure obtained was 0,000 (p<0.05). 
Therefore the average of osteoblast cell on each group was 
a significant difference (Table 1 and 2).
discussion
Hydroxyapatite has been used for a variety of 
biomedical applications, including matrices for drug 
release control and bone tissue engineering materials. 
Hydroxyapatite is chemically similar to the inorganic 
component of bone matrix–a very complex tissue with 
general formula Ca10(OH)2(PO4)6. Hydroxyapatite 
exhibits strong affinity to host hard tissues. Chemical 
bonding with the host tissue offers hydroxyapatite a 
greater advantage in clinical applications compared to 
most other bone substitutes such as allografts or metallic 
implants. The main advantages of hydroxyapatite are its 
biocompatibility, slow biodegradability in situ, and good 
osteoconductive capabilities. Hydroxyapatite exhibits 
excellent biocompatibility with soft tissues such as skin, 
muscle and gums and also has been widely used to repair 
hard tissues. Common uses include bone repair, bone 
augmentation, as well as coating of implants or acting as 
fillers in bone or teeth.8,9 
Bone healing includes a series of highly reproducible 
and rigidly controlled biologic events (inflammation, 
granulation tissue formation, epithelium formation and 
tissue remodelling) which begin with chemo attraction 
of cells that accumulate and debride the injured tissue, 
foreign material, and microbial cells. HA possesses various 
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Figure 1. Alveolar bone tissue preparations showing the existence of osteoblast quantity on (A)  
hydroxyapatite group; (B) Hydroxyapatite combined with HA metronidazole group; and 
(C) Control group. 
 
Table 1. The mean and standard deviation of the number of osteoblasts cells  
No.  Group N 
 
X +SD 
  
Sig  
1. Hydroxyapatite 9 14.00 + 2.739 0.00 
2.  Hydroxyapatite + HA metronidazole 9 19.00 + 1.500 0.00 
3. Controlled 9 3.56 +1.236 0.00 
 
 
Table 2. Significancy of Tukey HSD test  
 
Tukey HSD                                                                                               Multiple Comparisons 
 Dependent Variable (I) group (J) group Mean Difference (I-
J) 
Std. 
Error 
Sig. 
    Osteoblast 
HA 
Hap + HA -8,222* ,651 ,000 
control 7,222* ,651 ,000 
HAp + HA  HA  8,222* ,651 ,000 
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Figure 1. Alveolar bone tissue preparations showing the existence of osteoblast quantity on (A) hydroxyapatite group; 
(B) hydroxyapatite combined with HA metronidaz le group; and (C) c trol group.
Table 1. The mean and standard deviation of the number of osteoblasts cells 
No.  Group N X ±SD Sig 
1. Hydroxyapatite 9 14.00 ± 2.739 0.00
2. Hydroxyapatite + HA metronidazole 9 19.00 ± 1.500 0.00
3. Controlled 9 3.56 ±1.236 0.00
Dental Journal (Majalah Kedokteran Gigi) p-ISSN: 1978-3728; e-ISSN: 2442-9740. Accredited No. 56/DIKTI/Kep./2012.
Open access under CC-BY-SA license. Available at http://e-journal.unair.ac.id/index.php/MKG
DOI: 10.20473/j.djmkg.v48.i4.p204-208
207Setiawatie/Dent. J. (Majalah Kedokteran Gigi) 2015 December; 48(4): 204–208
physiological and structural functions, which include 
cellular and extracellular interactions with growth factors 
and regulation of the osmotic pressure and tissue lubrication. 
All these functions help in maintaining the structural and 
homeostatic integrity of the tissue. These biopolymers 
are completely biodegradable and support the growth of 
fibroblasts, osteoblast, chondrocytes and mesenchymal 
stem cells. Many proteins play a role in binding HA, 
namely, fibrinogen, fibrin, fibronectin, and collagen. All 
these molecules play an important role in wound healing.10 
The mechanisms by which HA promote bone formation 
were attributed to some actions. HA accelerated bone 
regeneration by means of chemotaxis, proliferation and 
successive differentiation of mesenchymal cells. HA 
increased alkaline phosphatase and hence stimulate cell 
mineralization. HA allowed the early deposition of osteoid 
tissue by providing a scaffold on which osteoprogenitor 
cell attached and so stimulated osteoblastic differentiation. 
Furthermore, the anti-inflammatory ability of exogenous 
HA may reduce the postsurgical inflammation and bacterial 
contamination when added to the surgical site and finally 
improve the surgical outcomes. Through recognition of 
its viscoelastic nature, HA can influence the cell functions 
that modify the surrounding cellular and the extracellular 
micro and macro environments. The viscoelastic properties 
of the material may slow the penetration of viruses, and 
bacteria, a feature of particular interest in the treatment of 
periodontal diseases.11
In this study a good response is seen in the use of a 
combination of hydroxyapatite and HA metronidazole 
compared with merely using hydroxyapatite. It is seen from 
the increasing number of osteoblasts in the healing process 
of the male wistar rats’ sockets, because HA is distributed 
by polysaccharide components of the extracellular matrix 
of connective tissue and bone marrow which has a function, 
among others, to facilitate cell migration, cell movement, 
cell interaction, cell matrix adhesion, differentiation during 
the formation and tissue repair and regeneration. HA acting 
on mineralized tissue and non-mineralized is found in the 
extracellular space of the entire tissues and synthesized in 
the cellular plasma membrane. HA serves to accelerate the 
process of regeneration by way of chemotaxis, proliferation 
and differentiation of mesenchymal cells and share the role 
as a bone induction with osteogenic substance such as bone 
morphogenetic protein-2 and osteopontin.12 In vitro studies 
HA is known to have a role in improving the formation 
of osteoblasts of the bone by increasing differentiation 
and migration of mesenchymal cells.13 HA shares a role 
in inducing bone with the osteogenic substrate such as 
calcitonin and bone morphogenic protein (BMP). BMP are 
the growth factors generally known to stimulate new bone 
formation.12-14 HA is recognized by specific cell receptor 
CD44 acting as selective and protective quote around cell 
membrane. CD 44 can exist in numerous isoforms. HA 
binding properties of CD44 are determined by the isoform 
and the cell type on which it is expressed. HA participates 
in tissue repair and wound healing and is used topically as 
anti inflammatory and anti-oedematous agent. The anti-
inflammatory effect may be due to action of exogenous 
hyaluronan as a scavenger by draining prostaglandins, 
metalloproteinases and other bioactive molecules increases 
proliferation, metabolism and cell migration, thereby 
accelerating bone healing.15,16 
Recent studies on regenerative surgical procedures 
indicate that reduction of bacterial burden at the wound 
site may improve the clinical outcome of regenerative 
therapy. The most common chemotherapeutic agents are 
antimicrobials and anti-inflammatory drugs. They are 
administered either systemically or topically. Topical 
antimicrobial agents for the treatment of bacterial anaerob 
include metronidazole. Metronidazole is a derivative of 
nitroimidazole, it has antiprotozoal and antibacterial action. 
The mechanism of action of metronidazole is in biochemical 
reconstruction of its 5-nitrogroup by intracellular transport 
proteins of anaerobic bacteria and protozoa. Recovered 
5-nitrogroup of metronidazole is reacted with the DNA of 
microorganism cell by inhibiting the synthesis of nucleic 
acids, which leads to the death of the bacteria. 7 
Tissue damage or impaired bone healing causes bacterial 
infection is a secondary result. Acute alveolar osteitis is a 
relatively common complication of the routine extraction 
of teeth. Antibacterial strategies have shown more promise. 
Preoperative good results have been obtained with topical 
antibiotics including clindamycin, metronidazole and 
tetracycline.7
In the research, metronidazole was choosed as tropical 
antibiotic because its good safety profile, low risk of allergy 
and effectiveness against pathogens which cause oral 
Table 2. Significancy of Tukey HSD test 
Tukey HSD Multiple Comparisons
 Dependent Variable (I) group (J) group Mean Difference (I-J) Std. error Sig.
 Osteoblast
HA
Hap + HA -8,222* ,651 ,000
control 7,222* ,651 ,000
HAp + HA 
HA 8,222* ,651 ,000
control 15,444* ,651 ,000
control
HAp -7,222* ,651 ,000
HAp + HA -15,444* ,651 ,000
*. The mean difference is significant at the 0.05 level.  HAp : Hydroxypatite
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infections. Metronidazole is particularly suitable due to its 
restricted spectrum of activity against obligate anaerobes 
and its limited side-effects. Metronidazole is classified 
in the WHO essential Medicines List as antiamoebic, 
antigiardiasis, and antibacterial. Since infection control 
is one modifiable factor, which can be controlled by the 
clinician, to so attempts have been made to incorporate 
metronidazole which is an antimicrobial drug along with 
hyaluronic acid gel to prevent bacterial contamination to be 
utilized as a graft material. Gel with metronidazole improved 
wound healing during the 1st week after surgery owing to 
maximum growth factor concentration and antibiotic action 
for the first 5-7 days. It was also observed that significant 
improvement in bone regeneration (reduction in defect size) 
occurred over the entire course of healing as evident by 
the rapid and more complete bone growth.17 Probably, the 
control of microbial population has resulted in successful 
healing and a good regeneration response.
For the research, HA was used as carrier of metronidazole 
because HA are promising in drug delivery applications. 
HA affects the permeability of tissues and the transfer of 
other medical substances. HA plays invaluable role not 
only as an independent medicine, but also as an instrument 
of slow transfer of other therapeutic agents to the tissues, 
providing also their controlled release. Biologically active 
components may be covalently or non-covalently bound to 
HA by varying of the concentration. It is possible to control 
the rate of its degradation or diffusion and, therefore, the 
speed of delivery of a medicine to the tissues. HA creates a 
depot of a medicine in the place of application and gradually 
collapsing frees a medicine, improving its pharmacological 
profile and preventing the development of possible adverse 
reactions. Viscoelastic properties and shear thinning 
character was strongly dependent on pH. Structured systems 
were obtained at pH 3, with an increase of several orders 
of magnitude in zero-shear viscosity values.18 
The most recent research shows that HA assists the 
process of repair in both the hard and soft tissues. HA 
has a high capacity of water holding-one molecule of 
hyaluronic acid binds 200-300 water molecules. Together 
with other proteoglycans hyaluronic acid is a member of 
the extracellular matrix. Due to its physical and chemical 
properties such as high viscosity contributes to the 
manifestation of numerous functions of connective tissue. 
HA affects the permeability of tissues and the transfer of 
other medical substances. A clinical application of HA 
membranes, gels, and sponges during the surgical therapy 
may reduce the bacterial contamination of surgical wound 
site, thereby, lessening the risk of postsurgical infection 
and promoting more predictable regeneration.19,20 In 
conclusion adjunctive application of HA metronidazole to 
hydroxyapatite after tooth extraction increase the number 
of osteoblast in the treatment of bone defects on a wistar 
rat model. 
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